Although studies show protective effects of 17 -estradiol (E 2 ) or prolactin (PRL) treatment in male rats following trauma-hemorrhage (T-H), the mechanism of the salutary effects of these agents remain unknown. Since E 2 modulates PRL receptor (PRL-R) expression in the liver, we examined whether E 2 treatment following T-H has any effects on hepatic PLR-R gene expression. Male Sprague-Dawley rats were subjected to trauma (i.e., 5cm midline laparotomy) and hemorrhage (35-40 mmHg for 90 min followed by fluid resuscitation (Ringer's lactate)) or sham operation and the treated with E 2 (50 g/kg BW, subcutaneously) or vehicle immediately before resuscitation. Liver samples were collected at 3 h thereafter and PRL-R mRNA expression determined by PCR. Liver expression of PRL-R short form gene was unaffected by T-H, whereas that of long form gene was suppressed. Treatment of T-H rats with E 2 significantly increased PRL-R short form gene expression and normalized PRL-R long form gene expression to sham levels. In the isolated hepatocytes, PRL-R short form gene expression was predominant as compared to the long form gene. In contrast, only short form was detected in Kupffer cells. In vitro treatment by E 2 demonstrated an increase in the PRL-R long form gene in hepatocytes, but E 2 had no effect on PRL-R short form gene expression in either the Kupffer cells or hepatocytes. Thus, E 2 treatment following T-H in males appears to directly upregulate PRL-R long form gene expression in hepatocytes. However, the upregulation of PRL-R short form might involve the interaction of multiple cell type in the liver.
INTRODUCTION
A body of evidence has shown that female sex hormones, i.e., estradiol (E 2 ) and prolactin (PRL), have a protective role on immune and organ functions under stressful conditions such as trauma-hemorrhage (T-H) (8, 18, 19) . Studies have also shown that proestrus female rats, which have high plasma E 2 and PRL levels, do not demonstrate depression in immune functions (2, 3, 19) or cardiac and hepatic functions (13) following T-H. With regards to the liver, the release of proinflammatory cytokines by the Kupffer cells following T-H is significantly attenuated in proestrus females compared to males (20) . Furthermore, the elevation in plasma alanine amino transferase (ALT) and decreased indocyanine green (ICG) clearance observed in males following T-H is attenuated in proestrus females under those conditions (13) . Additionally, elevation of plasma E 2 or PRL levels by pretreatment in male animals prior to T-H resulted in normalized immune functions and improved cardiac and hepatic functions (14, 18, 19, 22) . In view of the above results, E 2 and PRL have been proposed as novel adjuncts in the treatment of T-H. However, the precise mechanism by which female sex hormones mediate these observed beneficial effects remains poorly understood.
PRL, a single chain 24-kDa protein, has multiple physiologic functions including lactation, reproduction, growth and development, water and electrolyte balance, and immunoregulation (5) . PRL is promptly secreted from the anterior pituitary gland in response to a severe stress and the activation of PRL receptor (PRL-R) leads to the modulation of gene expression in target organs (5) . Two different PRL-R gene subtypes have been identified in the rats, i.e., short and long forms (30) . Although the gene expression of PRL-R long form is predominant compared to short form in many organs (23) , this expression pattern is reversed in the liver. Nevertheless, it remains unknown whether the altered expression of each receptor subtype occurs in the liver in response to T-H. Furthermore, the expression pattern of PRL-R subtype in different cell types of the liver has not been fully investigated under normal or pathophysiological conditions. E 2 and PRL have a mutual endocrine relationship and both hormones have multiple effects on immune and organ functions (23) . E 2 has been shown to stimulate pituitary PRL production and secretion (9, 10) . E 2 administration also increases the expression of PRL-R in the brain (21) , mammary gland (7), ovary (33) , and liver (30, 34) . Since both PRL and E 2 treatment elicit similar protective effects on immune and hepatic functions following T-H (14, 18, 19, 22) , it is pertinent to determine whether E 2 has any effects on the expression of PRL-R gene in this model. This might help to understand part of the mechanism of salutary effects of E 2 on the hepatic damage following T-H. The aim of this study therefore was to investigate whether there are any alterations in the expression of PRL-R in the liver following T-H with and without the administration of a single dose of E 2 . Additionally, hepatocytes and Kupffer cells were isolated after T-H to elucidate the different patterns of PRL-R subtype gene expression in each cell type.
Furthermore, the direct effects of E 2 on PRL-R gene expression in each cell type were determined by incubating the isolated cells with different concentrations of E 2 . Experimental groups. The rats were randomly assigned to the following three treatment groups: SV; sham-operated animals with vehicle treatment, HV; T-H animals with vehicle treatment, HE; T-H animals with E 2 treatment. E 2 ( -estradiol 3-benzoate; Sigma, St. Louis, MO) was prepared by dissolving in corn oil (Sigma) and was injected subcutaneously (50 g/kg body weight) just before the onset of resuscitation. An equal amount of corn oil (1 mL/kg) was used for the vehicle treatment. The dose of E 2 used was based on our previous study which revealed hepatoprotective effects of E 2 following T-H (21). Furthermore, the time period of the study was 3 h following E 2 or vehicle treatment. This time point was chosen to examine the early changes in gene expression following E 2 treatment. In separate experiments, hepatocytes and Kupffer cells were isolated following T-H to examine the direct effects of E 2 on the PRL-R gene expression in each cell type.
MATERIALS AND METHODS

Animals
Trauma-hemorrhage procedure. The rats were fasted overnight but were allowed free access to water before the experiment. After an anesthesia by isoflurane (Halocarbon Lab., River Edge, NJ) inhalation, soft tissue trauma (i.e., 5-cm midline laparotomy) was produced. After Briefly, 1 10 6 cells dissolved and frozen in 1 mL of Trizol reagent were thawed and incubated at room temperature for 5 min. Then 0.2 ml of chloroform was added, followed by vigorous shaking and incubation at room temperature for 2-3 min. The sample was then centrifuged for 10 min at 12,000g at 4°C for phase separation. The aqueous phase was carefully withdrawn and 0.5 ml of isopropyl alcohol was added. After incubation at room temperature for 10 min, samples were centrifuged at 12,000g at 4°C to precipitate out the RNA. The RNA pellet was washed once with 1 ml of 80% (v/v) ethanol and centrifuged at 7,500g for 5 min at 4°C. The RNA pellet was then air dried for 10 min at room temperature and dissolved in DEPC treated distilled water, and stored at -80°C. RNA concentration and purity were determined on a spectrophotometer -actin was used as an internal control. Primers used in this procedure are listed in Table 1 .
Common forward sequence was used for the amplification of a cDNA fragment derived from both PRL-R short and long form. The PCR reactions were carried out in a gradient Mastercycler (Eppendorf, Westbury, NY). The first cycle for PCR was carried out at 95 C for 15 min. The amplification was carried out with 35 cycles at 94 C for 1 min, 58 C for 1 min and 72 C for 1 min, followed by an additional 10 min of extension at 72 C. The number of reaction cycle was determined in a range which showed exponential amplification for PRL-R short, long, andactin. The PCR products were electrophoresed on 1.5% agarose gel stained with ethidium bromide. The intensity of cDNA bands was measured in the 500 Fluorescence ChemiImager Statistical analysis. There were six to nine animals in each group. Results are presented as mean standard error (SE). One-way ANOVA followed by the Student-Newman-Keuls test for multiple comparisons was used to determine significant differences among the experimental groups. When criteria for parametric testing were violated the appropriate non-parametric (Mann-Whitney U-test) was used. P value <0.05 was considered to indicate a significant difference.
RESULTS
Plasma E 2 and PRL levels. At 3 hrs following E 2 treatment, plasma E 2 levels were significantly increased in T-H group (Fig 1A) . In contrast, plasma PRL levels did not show any significant difference in sham-vehicle, T-H vehicle or T-H estradiol treated and the average plasma PRL concentration of all groups were within the normal range of male rats (8-33 ng/mL;
Fig 1B).
PRL-R gene expression in crude liver homogenate. Total hepatic mRNA expression for PRL-R short form did not change after T-H compared to sham in vehicle treated rats.
However, E 2 treatment significantly increased the expression in the T-H group (Fig 2A) . In contrast, the expression of PRL-R long form gene was significantly depressed in T-H vehicle group as compared to Sham vehicle and was restored in the E 2 treated group (Fig 2B) .
PRL-R gene expression in isolated hepatocytes and Kupffer cells. PRL-R gene
expression in purified hepatocytes and Kupffer cells stimulated by E 2 in vitro following T-H was determined to elucidate which cell type was responsible for the altered expression of PRL-R gene in the total liver homogenate. When the same amount of template and same number of amplification cycles were used for RT-PCR, differences in the amount of gene expression for each receptor type was observed in hepatocytes and Kupffer cells (Fig 3) . In hepatocytes, the mRNA expression for PRL-R short form was significantly higher than long form both in sham and T-H group (Fig 3) . Interestingly, the expression of PRL-R short form gene was detected in isolated Kupffer cells but the level was significantly lower compared to the level observed in hepatocytes from both sham and T-H group (Fig 3) . Furthermore, no PRL-R long form gene expression was detected in Kupffer cells. Additionally, PRL-R long form gene expression in hepatocytes was significantly lower in the T-H group compared to sham group. These results are consistent with the observation using the liver homogenates.
The effects of in vitro estradiol treatment on the PRLR expression. Hepatocytes and
Kupffer cells were incubated with different concentrations of E 2 (0, 0.5, 5, and 50 nM) to determine whether E 2 directly alters the expression of PRL-R gene. Stimulation with E 2 did not alter PRL-R short form gene in either hepatocytes or Kupffer cells isolated following T-H (Fig.   4A) . However, the downregulated expression of PRL-R long form gene following T-H in the hepatocytes was restored by the treatment of E 2 ( Fig. 4B, C) . No such change in PRL-R long form gene expression was observed in the cells isolated from sham animals.
DISCUSSION
To the best of our knowledge, this is the first study to show that the hepatic expression of PRL-R gene is altered following T-H and can be modulated by a single administration of E 2 .
Secondly, our findings demonstrate a unique expression pattern of PRL-R genes in hepatocytes and Kupffer cells after injury which has not previously been reported. The distribution of PRL-R immunoreactivity detected by anti-PRL-R antibodies has been shown to be similar to the expression of PRL-R gene, although these were not entirely parallel (4, 14, 26) . Furthermore, during ontogeny or in response to estrogen treatment, the rat liver increases both mRNA levels and binding levels of PRL-R (14). These results therefore collectively suggest that PRL-R gene expression in rat liver is regulated similarly at the transcriptional and translational levels. In view of this, we examined the expression of PRL-R gene in order to understand and extrapolate the functional regulation of PRL-R system following T-H with or without E 2 treatment.
There is a delicate regulation and mutual interaction between E 2 and PRL. Studies have
shown that E 2 upregulates the expression of PRL-R gene in various organs (17, 29, 31) . In the liver, PRL-R gene expression has been reported to be upregulated in response to E 2 administration (1,12,32). However, neither form of PRL-R gene was found to be upregulated by Interestingly, the expression of PRL-R long form gene in hepatocytes is significantly downregulated following T-H compared to that of sham. Furthermore, this depressed expression was restored with E 2 treatment in the in vitro study. These observations are similar to the pattern of PRL-R long form gene modification obtained from the liver homogenates in the in vivo study.
The beneficial effects of PRL for the treatment of T-H-induced hepatic damage have been shown in our previous reports (14) . Increased plasma PRL levels by metoclopramide treatment significantly improved the depressed hepatocellular function following T-H, which was assessed by the indocyanine green clearance technique (14) . Interestingly, similar beneficial effect on indocyanine green clearance was observed by E 2 treatment within the same model (22) . We therefore propose that the beneficial effects of E 2 are partly mediated by its effect on PRL-R modulation. PRL has other effect on the functions of the hepatocytes. Reports have shown that PRL stimulates the regeneration in hepatocytes following partial hepatectomy via the activation of protein kinase C (6). It could be therefore be postulated that PRL contributes to the regeneration processes of the damaged liver since hepatocyte damage does occur following T-H (6). Therefore, the restored expression of PRL-R long form gene in the hepatocytes following E 2 treatment might have protective effects in preventing the hepatocyte damage following T-H.
In contrast to PRL-R long form, no effect of E 2 on PRL-R short form gene expression in hepatocytes was observed in the in vitro study despite its increase in the in vivo studies using A.
C.
